Second-Tier Test for Quantification of Alloisoleucine and Branched-Chain Amino Acids in Dried Blood Spots to Improve Newborn Screening for Maple Syrup Urine Disease (MSUD)
Open Access
- 1 March 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 54 (3), 542-549
- https://doi.org/10.1373/clinchem.2007.098434
Abstract
Background: Newborn screening for maple syrup urine disease (MSUD) relies on finding increased concentrations of the branched-chain amino acids (BCAAs) leucine, isoleucine, and valine by tandem mass spectrometry (MS/MS). d-Alloisoleucine (allo-Ile) is the only pathognomonic marker of MSUD, but it cannot be identified by existing screening methods because it is not differentiated from isobaric amino acids. Furthermore, newborns receiving total parenteral nutrition often have increased concentrations of BCAAs. To improve the specificity of newborn screening for MSUD and to reduce the number of diet-related false-positive results, we developed a LC-MS/MS method for quantifying allo-Ile.Methods: Allo-Ile and other BCAAs were extracted from a 3/16-inch dried blood spot punch with methanol/H2O, dried under nitrogen, and reconstituted into mobile phase. Quantitative LC-MS/MS analysis of allo-Ile, its isomers, and isotopically labeled internal standards was achieved within 15 min. To determine a reference interval for BCAAs including allo-Ile, we analyzed 541 dried blood spots. We also measured allo-Ile in blinded samples from 16 MSUD patients and 21 controls and compared results to an HPLC method.Results: Intra- and interassay imprecision (mean CVs) for allo-Ile, leucine, isoleucine, and valine ranged from 1.8% to 7.4%, and recovery ranged from 91% to 129%. All 16 MSUD patients were correctly identified.Conclusions: The LC-MS/MS method can reliably measure allo-Ile in dried blood spots for the diagnosis of MSUD. Applied to newborn screening as a second-tier test, it will reduce false-positive results, which produce family anxiety and increase follow-up costs. The assay also appears suitable for use in monitoring treatment of MSUD patients.Keywords
This publication has 14 references indexed in Scilit:
- Long-Term Stability of Amino Acids and Acylcarnitines in Dried Blood SpotsClinical Chemistry, 2007
- Maple syrup urine disease: Favourable effect of early diagnosis by newborn screening on the neonatal course of the diseaseJournal of Inherited Metabolic Disease, 2006
- Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type IMolecular Genetics and Metabolism, 2006
- Main ReportGenetics in Medicine, 2006
- Method for the quantification of underivatized amino acids on dry blood spots from newborn screening by HPLC–ESI–MS/MSJournal of Chromatography B, 2006
- Atypical phenotype in a boy with a maple syrup urine diseaseJournal of Inherited Metabolic Disease, 2006
- Making the case for objective performance metrics in newborn screening by tandem mass spectrometryMental Retardation and Developmental Disabilities Research Reviews, 2006
- Quantification of trimethylsilyl derivatives of amino acid disease biomarkers in neonatal blood samples by gas chromatography-mass spectrometryAnalytical and Bioanalytical Chemistry, 2005
- Ion‐pairing reversed‐phase liquid chromatography/electrospray ionization mass spectrometric analysis of 76 underivatized amino acids of biological interest: a new tool for the diagnosis of inherited disorders of amino acid metabolismRapid Communications in Mass Spectrometry, 2005
- Development of a Method for Rapid Quantitation of Amino Acids by Liquid Chromatography-Tandem Mass Spectrometry (LC-MSMS) in Plasmacclm, 2000